Emmaus Life Sciences to Present at Maxim Group's Sickle Cell Disease Investor Conference on November 20 Nov 20, 2015 11:10am EST
Emmaus Life Sciences to Present at Upcoming Investor and Partnering Conferences During National Sickle Cell Awareness Month Sep 01, 2015 8:00am EDT
Emmaus Life Sciences to Present Phase 3 Sickle Cell Disease Clinical Trial Data Mar 31, 2015 10:00am EDT
Emmaus Life Sciences Phase 3 Sickle Cell Disease Trial Data Included In 2015 Highlights Of ASH Program Feb 02, 2015 9:00am EST
Emmaus Life Sciences To Present Phase 3 Sickle Cell Disease Trial Data At 56th American Society Of Hematology Annual Meeting Nov 24, 2014 8:43am EST
Emmaus Life Sciences Announces Positive Top-Line Results Of Its Phase 3 Clinical Trial For Sickle Cell Disease Mar 19, 2014 8:00am EDT
Emmaus Life Sciences Cancels Stock Held By AFH Holding & Advisory And Amir Heshmatpour Jul 01, 2013 8:00am EDT
